WHO
REGULATORY UPDATE
EUL for IVDs – Bundibugyo virus (BDBV) nucleic acid detection
Published: 8/13/2026Detected: 5/29/2026
Summary preview
Provides WHO-specific submission instructions for manufacturers seeking Emergency Use Listing (EUL) for in vitro nucleic acid detection IVDs intended for Bundibugyo virus disease (BDBV).
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountinfectious_disease
manufacturing
quality
clinical
safety
labeling
#WHO EUL
#in vitro diagnostics
#emergency use listing
#Bundibugyo virus
#nucleic acid detection
Official Source Document Source Verified
Access the original document directly from WHO.
More from WHO
- New Deadline for Submission: Request for Quotations (RFQ) from interested Notified Bodies - WHO Prequalification Assessment for Medical Devices10/2/2026
- PQT/AMD newsletter - Q3 2026, Issue 54 is now available10/2/2026
- PQ Webinar: Launch of WHO Prequalification of Medical Devices10/2/2026
- New EUL listing10/2/2026
- Prequalification of In Vitro Diagnostics: Scope Expansion10/2/2026